| CSIEX | RGAAX | CSIEX / RGAAX | |
| Total Expense Ratio | 0.90 | 1.37 | 66% |
| Annual Report Gross Expense Ratio | 0.90 | 1.37 | 66% |
| Fund Existence | 38 years | 24 years | - |
| Gain YTD | 1.891 | 1.533 | 123% |
| Front Load | 5% | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.8B | 336B | 1% |
| Annual Yield % from dividends | 0.18 | 0.00 | - |
| Returns for 1 year | -11.26 | 7.19 | -157% |
| Returns for 3 years | -1.42 | 48.54 | -3% |
| Returns for 5 years | 3.87 | 11.64 | 33% |
| Returns for 10 years | 84.20 | 98.14 | 86% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HGHCX | 26.01 | 0.20 | +0.77% |
| Hartford Healthcare C | |||
| VFSNX | 283.92 | 1.23 | +0.44% |
| Vanguard FTSE All-Wld ex-US SmCp Idx Ins | |||
| BMSYX | 15.54 | 0.02 | +0.13% |
| MFS Blended Research Mid Cap Eq R6 | |||
| JHARX | 10.57 | 0.01 | +0.09% |
| JHancock Multi-Asset Absolute Return R2 | |||
| FESMX | 13.60 | N/A | N/A |
| First Eagle U.S. SMID Cap Opportunity I | |||